2025-06-18 |
2025-06-16 |
B
Purchase
|
MOTT DAVID M
Non-Executive Director
|
1,000
+7.4%
3.63
USD 725,880
|
1,000
+7.4%
|
3.63
|
USD 100,000
|
|
2025-06-11 |
2025-06-09 |
B
Purchase
|
MOTT DAVID M
Non-Executive Director
|
1,000
+8.0%
3.69
USD 737,260
|
1,000
+8.0%
|
3.69
|
USD 100,000
|
|
2025-05-22 |
2025-05-20 |
S
Sale
|
Kelliher Mike
See Remarks
Officer
|
14,522
-4.9%
4.08
USD 59,270
|
14,522
-4.9%
|
4.08
|
USD 59,270
|
|
2025-05-22 |
2025-05-20 |
S
Sale
|
GRAMMER ELIZABETH A
See Remarks
Officer
|
5,992
-1.9%
4.08
USD 24,456
|
5,992
-1.9%
|
4.08
|
USD 24,456
|
|
2025-05-22 |
2025-05-20 |
PS
Planned sale
|
Renz Justin A
Chief Financial Officer
Officer
|
7,218
-1.7%
4.08
USD 29,460
|
7,218
-1.7%
|
4.08
|
USD 29,460
|
|
2025-05-22 |
2025-05-20 |
S
Sale
|
Williams Laura A
Chief Medical Officer
Officer
|
6,421
-1.6%
4.08
USD 26,207
|
6,421
-1.6%
|
4.08
|
USD 26,207
|
|
2025-05-22 |
2025-05-20 |
S
Sale
|
RAAB MICHAEL
President & CEO
Executive Director
|
46,817
-2.9%
4.08
USD 191,079
|
46,817
-2.9%
|
4.08
|
USD 191,079
|
|
2025-05-22 |
2025-05-20 |
PS
Planned sale
|
Foster Eric Duane
Chief Commercial Officer
Officer
|
2,507
-0.8%
4.08
USD 10,232
|
2,507
-0.8%
|
4.08
|
USD 10,232
|
|
2025-05-19 |
2025-05-15 |
B
Purchase
|
MOTT DAVID M
Non-Executive Director
|
100,000
+4.2%
3.29
USD 329,120
|
100,000
+4.2%
|
3.29
|
USD 329,120
|
|
2025-05-05 |
2025-05-02 |
B
Purchase
|
MOTT DAVID M
Non-Executive Director
|
381,377
+18.9%
4.22
USD 1,610,936
|
381,377
+18.9%
|
4.22
|
USD 1,610,936
|
|
2025-05-05 |
2025-05-02 |
S
Sale
|
RAAB MICHAEL
President & CEO
Executive Director
|
41,666
-2.5%
4.25
USD 177,168
|
41,666
-2.5%
|
4.25
|
USD 177,168
|
|
2025-04-08 |
2025-04-04 |
PS
Planned sale
|
RAAB MICHAEL
President & CEO
Executive Director
|
41,666
-2.5%
4.59
USD 191,151
|
41,666
-2.5%
|
4.59
|
USD 191,151
|
|
2025-03-07 |
2025-03-07 |
PS
Planned sale
|
RAAB MICHAEL
President & CEO
Executive Director
|
41,668
-2.5%
5.36
USD 223,199
|
41,668
-2.5%
|
5.36
|
USD 223,199
|
|
2025-02-26 |
2025-02-24 |
B
Purchase
|
MOTT DAVID M
Non-Executive Director
|
77,729
+4.0%
5.00
USD 388,738
|
77,729
+4.0%
|
5.00
|
USD 388,738
|
|
2025-02-21 |
2025-02-20 |
S
Sale
|
Williams Laura A
Chief Medical Officer
Officer
|
4,941
-1.6%
5.62
USD 27,783
|
4,941
-1.6%
|
5.62
|
USD 27,783
|
|
2025-02-21 |
2025-02-20 |
S
Sale
|
Renz Justin A
Chief Financial Officer
Officer
|
5,171
-1.8%
5.62
USD 29,077
|
5,171
-1.8%
|
5.62
|
USD 29,077
|
|
2025-02-21 |
2025-02-20 |
S
Sale
|
RAAB MICHAEL
President & CEO
Executive Director
|
22,964
-2.1%
5.62
USD 129,124
|
22,964
-2.1%
|
5.62
|
USD 129,124
|
|
2025-02-21 |
2025-02-20 |
S
Sale
|
GRAMMER ELIZABETH A
See Remarks
Officer
|
4,291
-2.3%
5.62
USD 24,128
|
4,291
-2.3%
|
5.62
|
USD 24,128
|
|
2025-01-31 |
2025-01-31 |
PS
Planned sale
|
RAAB MICHAEL
President & CEO
Executive Director
|
41,666
-3.6%
5.36
USD 223,355
|
41,666
-3.6%
|
5.36
|
USD 223,355
|
|
2025-01-22 |
2025-01-21 |
B
Purchase
|
MOTT DAVID M
Non-Executive Director
|
199,000
+11.4%
4.99
USD 992,672
|
199,000
+11.4%
|
4.99
|
USD 992,672
|
|